Zooxanthellatoxin‐A (ZT‐A), a novel polyhydroxylated long chain compound, isolated from a symbiotic marine alga Simbiodinium sp., caused aggregation in rabbit washed platelets in a concentration‐dependent manner (1–4 μM), accompanied by an increase in cytosolic Ca2+ concentration ([Ca2+]i).
ZT‐A did not cause platelet aggregation or increase [Ca2+]i in a Ca2+‐free solution, and Cd2+ (0.1‐1 mM), Co2+ (1–10 mM) and Mn2+ (1–10 mM) inhibited ZT‐A‐induced aggregation. SK&F96365 (1–100 μM), a receptor operated Ca2+ channel antagonist, and mefenamic acid (0.1–10 μM), a non‐specific divalent cation channel antagonist, inhibited platelet aggregation and the increase in [Ca2+], induced by ZT‐A.
Indomethacin (0.1–10 μM), a cyclo‐oxygenase inhibitor, and SQ‐29548 (0.1–10 μM), a thromboxane A2 (TXA2) receptor antagonist, inhibited platelet aggregation and the increase in [Ca2+]i induced by ZT‐A.
Methysergide (0.01‐1 μM), a 5‐HT2 receptor antagonist, inhibited ZT‐A‐induced platelet aggregation but did not affect the increase in [Ca2+]i induced by ZT‐A.
Tetrodotoxin (1 μM), a Na+ channel blocker and chlorpheniramine (1 μM), a H1‐histamine receptor antagonist, neither affected ZT‐A‐induced platelet aggregation nor the increase in [Ca2+]i induced by ZT‐A.
Genistein (1–100 μM), a protein tyrosine kinase inhibitor, and staurosporine (0.01‐1 μM), a protein kinase C inhibitor, also inhibited ZT‐A‐induced platelet aggregation.
The present results suggest that ZT‐A elicits Ca2+‐influx from platelet plasma membranes. The resulting increase in [Ca2+]i subsequently stimulates the secondary release of TXA2 from platelets. Furthermore, the response to ZT‐A may be associated with tyrosine phosphorylation.